Christopher Arthur,1 Jaroslav Cermak,2 Jacques Delaunay,3 Jirí Mayer,4 Grzegorz Mazur,5 Xavier Thomas,6 Agnieszka Wierzbowska,7 Mark M Jones,8 Erhan Berrak,8 Hagop Kantarjian9 1Department of Haematology, Royal North Shore Hospital, Sydney, NSW ...
Arthur C +9 more
doaj
AIM: To estimate a change in myelodysplasia in decitabine-treated patients with myelodysplastic syndromes (MDS)/MATERIAL AND METHODS: Thirteen MDS patients from a high-risk group were examined; 75 bone marrow puncture specimens and 67 bone marrow ...
V N Dvirnyk +6 more
doaj
Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance. [PDF]
Liu J +34 more
europepmc +1 more source
Methylation-associated downregulation of CRABP1 marks an aggressive malignant epithelial cell state in thyroid carcinoma. [PDF]
Fu T +9 more
europepmc +1 more source
CDO1 as a prognostic biomarker and therapeutic target in gastric cancer: Mechanistic insights into the PI3K/AKT-THBS1 axis and epigenetic reactivation by decitabine. [PDF]
Wang F +6 more
europepmc +1 more source
Concurrent Remission of Therapy-Related Acute Myeloid Leukemia and IgG-λ MGUS During Oral Decitabine-Cedazuridine: A Case Report. [PDF]
Niscola P +4 more
europepmc +1 more source
DNA Hypomethylation Is Not Cell Intrinsically Toxic to Polycomb Repressive Complex 2 Deficient Malignant Peripheral Nerve Sheath Tumors. [PDF]
Stahl MR +4 more
europepmc +1 more source
DNA Methylation Dynamics in <i>Eisenia andrei</i> Regeneration: The Effects of Time, Region, and a Hypomethylating Agent. [PDF]
Brotzki da Costa C +2 more
europepmc +1 more source
Synthetic lethality in TP53-mutant acute myeloid leukemia. [PDF]
Patel SA.
europepmc +1 more source
Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series. [PDF]
Ren Y +7 more
europepmc +1 more source

